MDOMF yields 1.69% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 5
Combined, MDOMF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MDOMF + JNJ for your $10,000?
Mandom Corporation engages in the manufacture and sale of cosmetics, perfumes, and quasi-drugs in Japan, Indonesia, and internationally. The company offers a range of products, including men's everyday grooming products, as well as general fashion items, such as hair styling, skin care, and body care products; and hair coloring, scalp care, and face care products under the Gatsby and Lúcido brands. It also provides a range of women's grooming and fashion items, such as hair styling and body care products comprises make-up and skin care items, as well as hair styling, coloring, and treatment products under the Bifesta, Pixy, Lúcido-L, and Pucelle brands. In addition, the company offers professional-use products and technologies to hair salons through distributors; and insurance agency, travel, and general services. It sells its products to drug stores and convenience stores through distributors. The company was formerly known as Tancho Corporation and changed its name to Mandom Corporation in April 1971. Mandom Corporation was incorporated in 1927 and is headquartered in Osaka, Japan.
Full MDOMF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.